A Study to Evaluate the Impact of Teriparatide on Clinical Fractures and Health Related Quality of Life (HRQoL) in Patients With Osteoporosis

Trial Profile

A Study to Evaluate the Impact of Teriparatide on Clinical Fractures and Health Related Quality of Life (HRQoL) in Patients With Osteoporosis

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 26 Mar 2017

At a glance

  • Drugs Teriparatide (Primary)
  • Indications Osteoporosis
  • Focus Therapeutic Use
  • Acronyms JFOS
  • Most Recent Events

    • 09 Feb 2016 New trial record
    • 12 Oct 2015 Interim results presented at the 37th Annual Meeting of the American Society for Bone and Mineral Research.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top